1. Comparison of the antibacterial activities of the quinolones BAY 12-8039, gatifloxacin (AM-1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin;Bauernfeind;J Antimicrob Chemother,1997
2. Structure-activity and structure-side-effect relationships for the quinolone antibacterials;Domagala;J Antimicrob Chemother,1994
3. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: A collaborative study;Gavan;J Clin Microbiol,1981
4. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone;Hosaka;Antimicrob Agents Chemother,1992
5. Jones RN, Pfaller MA, Doern GV, Verhoef J, Jones ME, Sader HS, SENTRY Study Group (1997) Initial report of longitudinal, international antimicrobial surveillance study (SENTRY): Alarming resistance rates in monitored sites (68 medical centers) in the USA, Canada, South America, and Europe (abstr. E-109). Proceedings of the 37th ICAAC. Washington, DC: American Society for Microbiology, pg. 133.